Literature DB >> 15293240

The Bellus-Claisen rearrangement.

Jozef Gonda1.   

Abstract

Among the reactions available to synthetic chemists for the construction of new C--C bonds, the Claisen rearrangement is one of the most powerful, elegant, and well-characterized methods. A genuinely new variant, the Bellus-Claisen rearrangement came to light a quarter of a century ago: The reaction of an allylic ether, thioether, or amine with a ketene leads through a [3,3] sigmatropic bond reorganization of a zwitterionic intermediate to an E unsaturated ester, thioester, or amide. When applied to cyclic allylic substrates, a ring-enlargement by four carbon atoms in one step provides medium-ring unsaturated E-configured lactones, thiolactones, and lactams. The scope of the Bellus-Claisen rearrangement and the optimum reaction conditions will be discussed in this Minireview.

Entities:  

Year:  2004        PMID: 15293240     DOI: 10.1002/anie.200301718

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  4 in total

Review 1.  Toward a symphony of reactivity: cascades involving catalysis and sigmatropic rearrangements.

Authors:  Amanda C Jones; Jeremy A May; Richmond Sarpong; Brian M Stoltz
Journal:  Angew Chem Int Ed Engl       Date:  2014-03-03       Impact factor: 15.336

2.  Enantioselective Allenoate-Claisen Rearrangement Using Chiral Phosphate Catalysts.

Authors:  Javier Miró; Tobias Gensch; Mario Ellwart; Seo-Jung Han; Hsin-Hui Lin; Matthew S Sigman; F Dean Toste
Journal:  J Am Chem Soc       Date:  2020-03-23       Impact factor: 15.419

3.  Enantiospecific synthesis of [2.2]paracyclophane-4-thiol and derivatives.

Authors:  Gareth J Rowlands; Richard J Seacome
Journal:  Beilstein J Org Chem       Date:  2009-03-12       Impact factor: 2.883

Review 4.  Recent Perspectives on Rearrangement Reactions of Ylides via Carbene Transfer Reactions.

Authors:  Sripati Jana; Yujing Guo; Rene M Koenigs
Journal:  Chemistry       Date:  2020-10-29       Impact factor: 5.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.